nodes	percent_of_prediction	percent_of_DWPC	metapath
Isometheptene—ADRA1A—Adrenoceptors—ADRA2C—attention deficit hyperactivity disorder	0.0566	0.0623	CbGpPWpGaD
Isometheptene—SLC18A2—Norepinephrine Neurotransmitter Release Cycle—SNAP25—attention deficit hyperactivity disorder	0.0389	0.0428	CbGpPWpGaD
Isometheptene—SLC18A2—Dopamine Neurotransmitter Release Cycle—SNAP25—attention deficit hyperactivity disorder	0.0389	0.0428	CbGpPWpGaD
Isometheptene—SLC18A2—Nicotine Activity on Dopaminergic Neurons—CHRNA4—attention deficit hyperactivity disorder	0.037	0.0407	CbGpPWpGaD
Isometheptene—SLC18A2—Nicotine Activity on Dopaminergic Neurons—DRD3—attention deficit hyperactivity disorder	0.0333	0.0366	CbGpPWpGaD
Isometheptene—SLC18A2—Na+/Cl- dependent neurotransmitter transporters—SLC6A3—attention deficit hyperactivity disorder	0.0332	0.0365	CbGpPWpGaD
Isometheptene—SLC18A2—Nicotine Activity on Dopaminergic Neurons—DRD4—attention deficit hyperactivity disorder	0.0323	0.0356	CbGpPWpGaD
Isometheptene—SLC18A2—Nicotine Activity on Dopaminergic Neurons—DRD2—attention deficit hyperactivity disorder	0.0301	0.0331	CbGpPWpGaD
Isometheptene—ADRA1A—Adrenoceptors—ADRA2A—attention deficit hyperactivity disorder	0.0297	0.0327	CbGpPWpGaD
Isometheptene—SLC18A2—Norepinephrine Neurotransmitter Release Cycle—MAOA—attention deficit hyperactivity disorder	0.0293	0.0322	CbGpPWpGaD
Isometheptene—SLC18A2—Dopaminergic Neurogenesis—SLC6A3—attention deficit hyperactivity disorder	0.023	0.0254	CbGpPWpGaD
Isometheptene—SLC18A2—Amine compound SLC transporters—SLC6A3—attention deficit hyperactivity disorder	0.023	0.0254	CbGpPWpGaD
Isometheptene—ADRA1A—Monoamine GPCRs—ADRA2C—attention deficit hyperactivity disorder	0.02	0.022	CbGpPWpGaD
Isometheptene—SLC18A2—Neurotransmitter Release Cycle—SNAP25—attention deficit hyperactivity disorder	0.0197	0.0217	CbGpPWpGaD
Isometheptene—ADRA1A—Monoamine GPCRs—DRD5—attention deficit hyperactivity disorder	0.0196	0.0216	CbGpPWpGaD
Isometheptene—SLC18A2—Synaptic Vesicle Pathway—SLC6A4—attention deficit hyperactivity disorder	0.0169	0.0186	CbGpPWpGaD
Isometheptene—SLC18A2—Synaptic Vesicle Pathway—SNAP25—attention deficit hyperactivity disorder	0.0169	0.0186	CbGpPWpGaD
Isometheptene—ADRA1A—Amine ligand-binding receptors—ADRA2C—attention deficit hyperactivity disorder	0.0168	0.0185	CbGpPWpGaD
Isometheptene—ADRA1A—Amine ligand-binding receptors—DRD5—attention deficit hyperactivity disorder	0.0165	0.0181	CbGpPWpGaD
Isometheptene—SLC18A2—forebrain—attention deficit hyperactivity disorder	0.0157	0.172	CbGeAlD
Isometheptene—SLC18A2—Neurotransmitter Release Cycle—MAOA—attention deficit hyperactivity disorder	0.0149	0.0164	CbGpPWpGaD
Isometheptene—SLC18A2—Transmission across Chemical Synapses—GABRQ—attention deficit hyperactivity disorder	0.0138	0.0152	CbGpPWpGaD
Isometheptene—ADRA1A—Monoamine GPCRs—HTR1B—attention deficit hyperactivity disorder	0.0119	0.0131	CbGpPWpGaD
Isometheptene—SLC18A2—SLC-mediated transmembrane transport—SLC9A9—attention deficit hyperactivity disorder	0.0118	0.0129	CbGpPWpGaD
Isometheptene—ADRA1A—Amine ligand-binding receptors—HRH3—attention deficit hyperactivity disorder	0.0114	0.0126	CbGpPWpGaD
Isometheptene—ADRA1A—Monoamine GPCRs—DRD1—attention deficit hyperactivity disorder	0.011	0.0122	CbGpPWpGaD
Isometheptene—ADRA1A—Monoamine GPCRs—DRD3—attention deficit hyperactivity disorder	0.0107	0.0118	CbGpPWpGaD
Isometheptene—SLC18A2—Neuronal System—GABRQ—attention deficit hyperactivity disorder	0.0106	0.0117	CbGpPWpGaD
Isometheptene—ADRA1A—Monoamine GPCRs—ADRA2A—attention deficit hyperactivity disorder	0.0105	0.0116	CbGpPWpGaD
Isometheptene—ADRA1A—Monoamine GPCRs—DRD4—attention deficit hyperactivity disorder	0.0104	0.0114	CbGpPWpGaD
Isometheptene—SLC18A2—midbrain—attention deficit hyperactivity disorder	0.0104	0.113	CbGeAlD
Isometheptene—ADRA1A—Amine ligand-binding receptors—HTR1B—attention deficit hyperactivity disorder	0.00999	0.011	CbGpPWpGaD
Isometheptene—ADRA1A—Monoamine GPCRs—DRD2—attention deficit hyperactivity disorder	0.00967	0.0106	CbGpPWpGaD
Isometheptene—ADRA1A—Amine ligand-binding receptors—DRD1—attention deficit hyperactivity disorder	0.00928	0.0102	CbGpPWpGaD
Isometheptene—SLC18A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—attention deficit hyperactivity disorder	0.00901	0.00992	CbGpPWpGaD
Isometheptene—ADRA1A—Amine ligand-binding receptors—DRD3—attention deficit hyperactivity disorder	0.00899	0.0099	CbGpPWpGaD
Isometheptene—ADRA1A—forebrain—attention deficit hyperactivity disorder	0.00891	0.0973	CbGeAlD
Isometheptene—ADRA1A—Amine ligand-binding receptors—ADRA2A—attention deficit hyperactivity disorder	0.00884	0.00973	CbGpPWpGaD
Isometheptene—ADRA1A—Amine ligand-binding receptors—DRD4—attention deficit hyperactivity disorder	0.00873	0.00961	CbGpPWpGaD
Isometheptene—SLC18A2—nervous system—attention deficit hyperactivity disorder	0.00853	0.0931	CbGeAlD
Isometheptene—SLC18A2—central nervous system—attention deficit hyperactivity disorder	0.00821	0.0897	CbGeAlD
Isometheptene—ADRA1A—Amine ligand-binding receptors—DRD2—attention deficit hyperactivity disorder	0.00813	0.00895	CbGpPWpGaD
Isometheptene—SLC18A2—cerebellum—attention deficit hyperactivity disorder	0.00802	0.0876	CbGeAlD
Isometheptene—ADRA1A—cardiovascular system—attention deficit hyperactivity disorder	0.00753	0.0823	CbGeAlD
Isometheptene—SLC18A2—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.00709	0.0078	CbGpPWpGaD
Isometheptene—ADRA1A—Monoamine GPCRs—HTR2A—attention deficit hyperactivity disorder	0.00677	0.00746	CbGpPWpGaD
Isometheptene—SLC18A2—brain—attention deficit hyperactivity disorder	0.00652	0.0712	CbGeAlD
Isometheptene—SLC18A2—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.00609	0.00671	CbGpPWpGaD
Isometheptene—SLC18A2—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00598	0.00658	CbGpPWpGaD
Isometheptene—SLC18A2—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.0057	0.00628	CbGpPWpGaD
Isometheptene—ADRA1A—Amine ligand-binding receptors—HTR2A—attention deficit hyperactivity disorder	0.00569	0.00627	CbGpPWpGaD
Isometheptene—SLC18A2—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.00567	0.00624	CbGpPWpGaD
Isometheptene—SLC18A2—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.00543	0.00598	CbGpPWpGaD
Isometheptene—SLC18A2—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.00505	0.00556	CbGpPWpGaD
Isometheptene—ADRA1A—nervous system—attention deficit hyperactivity disorder	0.00484	0.0528	CbGeAlD
Isometheptene—SLC18A2—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.00467	0.00514	CbGpPWpGaD
Isometheptene—ADRA1A—central nervous system—attention deficit hyperactivity disorder	0.00466	0.0509	CbGeAlD
Isometheptene—ADRA1A—cerebellum—attention deficit hyperactivity disorder	0.00455	0.0497	CbGeAlD
Isometheptene—SLC18A2—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.00434	0.00478	CbGpPWpGaD
Isometheptene—SLC18A2—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.00429	0.00473	CbGpPWpGaD
Isometheptene—SLC18A2—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.00426	0.00469	CbGpPWpGaD
Isometheptene—SLC18A2—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	0.00409	0.00451	CbGpPWpGaD
Isometheptene—SLC18A2—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.00387	0.00426	CbGpPWpGaD
Isometheptene—ADRA1A—GPCRs, Class A Rhodopsin-like—ADRA2C—attention deficit hyperactivity disorder	0.00386	0.00425	CbGpPWpGaD
Isometheptene—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD5—attention deficit hyperactivity disorder	0.00378	0.00417	CbGpPWpGaD
Isometheptene—ADRA1A—Calcium Regulation in the Cardiac Cell—CACNA1C—attention deficit hyperactivity disorder	0.00378	0.00416	CbGpPWpGaD
Isometheptene—ADRA1A—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.00376	0.00414	CbGpPWpGaD
Isometheptene—ADRA1A—brain—attention deficit hyperactivity disorder	0.0037	0.0404	CbGeAlD
Isometheptene—ADRA1A—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.00331	0.00364	CbGpPWpGaD
Isometheptene—SLC18A2—Neuronal System—COMT—attention deficit hyperactivity disorder	0.00329	0.00362	CbGpPWpGaD
Isometheptene—SLC18A2—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.00327	0.0036	CbGpPWpGaD
Isometheptene—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.00324	0.00357	CbGpPWpGaD
Isometheptene—ADRA1A—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.00262	0.00289	CbGpPWpGaD
Isometheptene—ADRA1A—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.00252	0.00277	CbGpPWpGaD
Isometheptene—ADRA1A—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.00247	0.00272	CbGpPWpGaD
Isometheptene—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.00229	0.00252	CbGpPWpGaD
Isometheptene—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.00225	0.00247	CbGpPWpGaD
Isometheptene—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.00213	0.00235	CbGpPWpGaD
Isometheptene—ADRA1A—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.00212	0.00234	CbGpPWpGaD
Isometheptene—SLC18A2—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.00208	0.00229	CbGpPWpGaD
Isometheptene—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.00206	0.00227	CbGpPWpGaD
Isometheptene—ADRA1A—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.00203	0.00223	CbGpPWpGaD
Isometheptene—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.002	0.00221	CbGpPWpGaD
Isometheptene—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00196	0.00216	CbGpPWpGaD
Isometheptene—ADRA1A—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00193	0.00212	CbGpPWpGaD
Isometheptene—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.00187	0.00205	CbGpPWpGaD
Isometheptene—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.00183	0.00201	CbGpPWpGaD
Isometheptene—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00177	0.00195	CbGpPWpGaD
Isometheptene—ADRA1A—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00174	0.00191	CbGpPWpGaD
Isometheptene—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.00172	0.00189	CbGpPWpGaD
Isometheptene—ADRA1A—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00171	0.00188	CbGpPWpGaD
Isometheptene—ADRA1A—G alpha (q) signalling events—HTR2A—attention deficit hyperactivity disorder	0.00169	0.00186	CbGpPWpGaD
Isometheptene—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.0016	0.00176	CbGpPWpGaD
Isometheptene—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—attention deficit hyperactivity disorder	0.00151	0.00167	CbGpPWpGaD
Isometheptene—ADRA1A—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.0015	0.00165	CbGpPWpGaD
Isometheptene—ADRA1A—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00142	0.00157	CbGpPWpGaD
Isometheptene—ADRA1A—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.0014	0.00154	CbGpPWpGaD
Isometheptene—ADRA1A—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.00139	0.00153	CbGpPWpGaD
Isometheptene—ADRA1A—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.00135	0.00148	CbGpPWpGaD
Isometheptene—ADRA1A—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.00132	0.00146	CbGpPWpGaD
Isometheptene—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.00131	0.00144	CbGpPWpGaD
Isometheptene—ADRA1A—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00131	0.00144	CbGpPWpGaD
Isometheptene—ADRA1A—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00129	0.00142	CbGpPWpGaD
Isometheptene—ADRA1A—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00127	0.00139	CbGpPWpGaD
Isometheptene—ADRA1A—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.00122	0.00134	CbGpPWpGaD
Isometheptene—ADRA1A—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00114	0.00125	CbGpPWpGaD
Isometheptene—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.00112	0.00123	CbGpPWpGaD
Isometheptene—ADRA1A—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000967	0.00106	CbGpPWpGaD
Isometheptene—ADRA1A—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000889	0.000979	CbGpPWpGaD
Isometheptene—ADRA1A—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000878	0.000967	CbGpPWpGaD
Isometheptene—ADRA1A—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000853	0.000939	CbGpPWpGaD
Isometheptene—ADRA1A—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000845	0.00093	CbGpPWpGaD
Isometheptene—ADRA1A—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000786	0.000865	CbGpPWpGaD
Isometheptene—ADRA1A—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000768	0.000845	CbGpPWpGaD
Isometheptene—ADRA1A—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000764	0.000841	CbGpPWpGaD
Isometheptene—ADRA1A—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000761	0.000838	CbGpPWpGaD
Isometheptene—ADRA1A—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000748	0.000824	CbGpPWpGaD
Isometheptene—ADRA1A—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000748	0.000823	CbGpPWpGaD
Isometheptene—ADRA1A—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000739	0.000813	CbGpPWpGaD
Isometheptene—ADRA1A—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000734	0.000808	CbGpPWpGaD
Isometheptene—ADRA1A—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000714	0.000785	CbGpPWpGaD
Isometheptene—ADRA1A—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000691	0.000761	CbGpPWpGaD
Isometheptene—ADRA1A—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000688	0.000758	CbGpPWpGaD
Isometheptene—ADRA1A—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000679	0.000748	CbGpPWpGaD
Isometheptene—ADRA1A—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000671	0.000739	CbGpPWpGaD
Isometheptene—ADRA1A—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000625	0.000688	CbGpPWpGaD
Isometheptene—ADRA1A—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000519	0.000571	CbGpPWpGaD
Isometheptene—ADRA1A—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000482	0.000531	CbGpPWpGaD
Isometheptene—ADRA1A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000453	0.000499	CbGpPWpGaD
Isometheptene—ADRA1A—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000438	0.000482	CbGpPWpGaD
Isometheptene—ADRA1A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000422	0.000464	CbGpPWpGaD
Isometheptene—ADRA1A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000408	0.000449	CbGpPWpGaD
Isometheptene—ADRA1A—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000401	0.000442	CbGpPWpGaD
Isometheptene—ADRA1A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000396	0.000436	CbGpPWpGaD
Isometheptene—ADRA1A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000369	0.000406	CbGpPWpGaD
Isometheptene—ADRA1A—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000259	0.000285	CbGpPWpGaD
Isometheptene—ADRA1A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000137	0.000151	CbGpPWpGaD
